Research Article: Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR Signaling Pathway in the Microbiota–Gut–Brain Axis
Abstract:
Graphical Abstract:
Introduction:
Ischemic stroke (IS) is a common acute cerebrovascular accident, which accounts approximately for % of all strokes, and has become one of the leading causes of death and disability worldwide. Recombinant tissue plasminogen activator (rt-PA) is an acute IS treatment that is limited to use within . hours of IS onset. However, due to the narrow time window and potential bleeding risk, only –% of IS patients worldwide benefit from thrombolysis, and only .–.% in China. , Brain ischemic injury involves multiple…
Read more